
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine f... Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.79 | 6.12403100775 | 12.9 | 14.05 | 12.755 | 2313750 | 13.2980241 | CS |
4 | 0.73 | 5.63271604938 | 12.96 | 14.05 | 11.81 | 1743590 | 13.04327453 | CS |
12 | 0.945 | 7.41467242056 | 12.745 | 14.05 | 11.81 | 1670599 | 12.85513712 | CS |
26 | 2.17 | 18.8368055556 | 11.52 | 14.05 | 10.12 | 1979012 | 12.09874303 | CS |
52 | 0.99 | 7.79527559055 | 12.7 | 14.05 | 9.74 | 2054322 | 11.80083024 | CS |
156 | 1.31 | 10.5815831987 | 12.38 | 17.48 | 7.26 | 1928191 | 12.03352602 | CS |
260 | 9.27 | 209.728506787 | 4.42 | 21.39 | 1.8 | 2737767 | 10.47383772 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관